Pregnancy, prescription drugs

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

In the case of drug therapy during pregnancy, the embryo is always treated as well. This "additional" patient forces the patient to make particularly strict indications. The overriding principle should be that, on the one hand, the mother's health is restored and, on the other hand, that the developmental conditions for the embryo are not impaired. The following overviews refer to dermatologically relevant questions.

ContraindicationThis section has been translated automatically.

Contraindications for medication: Pregnancy ciphers according to "Red List
Group Assessment
1 Extensive use in humans did not give rise to any suspicion of an embryotoxic/teratogenic effect. Animal testing also did not provide any evidence of embryotoxic/teratogenic effects
2 Extensive use in humans did not give rise to any suspicion of an embryotoxic/teratogenic effect.
3 Extensive use in humans did not give rise to any suspicion of an embryonic/teratogenic effect. However, animal experiments also yielded indications of embryotoxic/teratogenic effects. These appear to be of no significance for humans.
4 There is insufficient experience of its use in humans. Animal experiments have not shown any evidence of embryotoxic/teratogenic effects.
5 There is insufficient experience of its use in humans.
6 There is insufficient experience of its use in humans. Animal experiments have shown evidence of embryotoxic/teratogenic effects.
7 There is an embryotoxic/teratogenic risk in humans (1st trimenon)
8 There is a fetotoxic risk in humans (2nd and 3rd trimester).
9 There is a risk of perinatal complications or damage in humans.
10 There is a risk of undesirable hormone-specific effects on the fruit in humans.
11 There is a risk of mutagenic/carcinogenic effects.

Note(s)This section has been translated automatically.

Further information can also be found at www.embryotox.de.

LiteratureThis section has been translated automatically.

  1. Schaefer C, Spielmann H (2001) Prescription of drugs during pregnancy and lactation. 6th edition, Urban & Fischer, S. 32-582
  2. Wohlrab J (2010) Dermatotherapy in pregnancy dermatologist 61: 1045-1051

TablesThis section has been translated automatically.

Pharmaceuticals

Embryonic period (1st-12th week of gestation)

Fetal period (from 13th week of gestation)

Peripartum period

Lactation period

ACE inhibitors

2

T

T

2

Acetylcysteine

1

1

1

1

Acetylsalicylic acid (low-dose unlimited)

2/E

2/E

2/E

2/E

Aciclovir

2

2

2

2

Acitretin

K

K

K

K

Ambroxol

1

1

1

1

Aminoglycosides

T

T

T

2

Amitryptilin

1

1

T

1

amphotericin B

2

2

2

2

Antidiabetics, oral

K

K

K

K

Atropine

1/E

1/E

1/E

1/E

Benzyl benzoate (external use)

1

1

1

1

ß-receptor blockers

1

1

E

1/2

ß-Sympathomimetics (for inhalation)

1

1

E

1

Biperidine

2

2

2

2

Bromhexine

1

1

1

1

Bromocriptine

2

T

T

T/E

Carbamazepine

T

2

T

T

Carbimazole

2

2

2

2

Cephalosporins

1

1

1

1

Cetirizine

2

2

2

1

Chloramphenicol

T

T

T

T

Chloroquine (antimalarial agent)

1

1

1

1

Chlorphenoxamine (external application)

1

1

1

1

Chlorpromazine

2

2

T

2

Cimetidine

2

2

2

2

Ciprofloxacin

2

2

2

2

Clarithromycin

2

2

2

2

Clemastine

1

1

1

2

Clofibrate

2

2

2

2

Clomethiazole

2

2

2

2

Clonidine

2

2

2

2

Clotrimazole

2

1

1

1

Codeine

1/E

1/E

1/E

1/E

Cotrimoxazole

2

2

2

2

Cromoglicic acid

1

1

1

1

Coumarin derivatives

K

2

K

2

Cyproterone acetate

K

K

K

K

1 = 1st choice product: Generally well tolerated during pregnancy and lactation. Also, these drugs should only be prescribed if their use is superior to a non-drug therapy.

2 = 2nd choice remedy: Only indicated when other therapeutic options fail. Often insufficient testing during pregnancy and lactation.

E = Single dose or low dosage for a maximum of 1-3 days.

K = Contraindicated: Because of embryo-fetotoxic potential, possible intolerance during lactation or because there is no rational indication during pregnancy. Extended prenatal diagnosis may be necessary.

T = Potentially toxic: Concerns embryo, foetus, newborn or breastfed infant. Use only in justified individual cases. In case of use, extended prenatal diagnostics may be necessary.


Pharmaceuticals

Embryonic period (1st-12th week of gestation)

Fetal period (from 13th week of gestation)

Peripartum period

Lactation period

Dextran

2

2

2

2

Diazepam

1

1/E

T

T

Diclofenac

1

T/E

T/E

E

Digoxin/digitoxin

1

1

1

1

Dihydralazine

1

1

1

1

Dihydroergotamine

2

2

T

2

Dimenhydrinate

2

2

2

1

Dimetinden

1

1

1

1

Diphenhydramine

1

1

T

1/E

Doxycycline

2

K

K

2

Doxylamine

1

1

1

1

Ergotamine tartrate

T

T

T

T

Erythromycin

1

1

1

1

Ethambutol

1

1

1

1

Etilefrin

2

2

2

2

Fenbufen

1

T/E

T/E

1

Fentanyl

1

1

T

2

Fluconazole

2

2

2

2

Furosemide

2

2

2

2

Gestagens (used as contact pills during lactation)

K

K

K

1

Glucocorticoids

2

2

2

2

Glycerol trinitrate

2

2

2

2

Gold compounds

2

2

2

2

Griseofulvin

2

2

2

2

Haloperidol

2

2

T

2

Heparins

1

1

T

1

Hydrochlorothiazide

2

2

2

2

Hydroxyethyl starch

1

1

1

1

Ibuprofen

1

T/E

T/E

1

Imipramine

1

1

T

1

Indomethacin

1

T/E

T/E

E

Insulin (human)

1

1

1

1

isoniazid + vitamin B6

1

1

1

1

Isotretinoin

K

K

K

K

Itraconazole

2

2

2

2

Iodide (iodine substitution)

1

1

1

1

Ketoconazole

2

2

2

2

Lithium salts

T

T

T

T

Local anaesthetics

1 1 1 1

Loratadine

2

2

2

1

Mebendazole

2

1

1

1

Meclizine

1

1

1

1

Mefloquine (malaria prophylaxis and therapy)

2

2

2

2

Metamizole

2

T

T

T

Methimazol

2

2

2

2

α-Methyldopa

1

1

1

1

Methylergometrin

K

K

T

T/E

Metoclopramide

2

2

2

2

Miconazole (local)

2

2

2

2

1 = 1st choice product: Generally well tolerated during pregnancy and lactation. Also, these drugs should only be prescribed if their use is superior to a non-drug therapy.

2 = 2nd choice remedy: Only indicated when other therapeutic options fail. Often insufficient testing during pregnancy and lactation.

E = Single dose or low dosage for a maximum of 1-3 days.

K = Contraindicated: Because of embryo-fetotoxic potential, possible intolerance during lactation or because there is no rational indication during pregnancy. Extended prenatal diagnosis may be necessary.

T = Potentially toxic: Concerns embryo, foetus, newborn or breastfed infant. Use only in justified individual cases. In case of use, extended prenatal diagnostics may be necessary.


Pharmaceuticals

Embryonic period (1st-12th week of gestation)

Fetal period (from 13th week of gestation)

Peripartum period

Lactation period

Nifedipine

2

2

2

1

Nitrendipine

2

2

2

2

Nitrofurantoin

2

2

2

2

Norfenefrin

2

2

2

2

norfloxacin

2

2

2

2

Nystatin

1

1

1

1

Estrogens

K

K

K

2

Ofloxacin

2

2

2

2

Opium alkaloids

1/E

1/E

T/E

T/E

Oxytocin

K

K

1

1

Paracetamol

1

1

1

1

Penicillamine (except M. Wilson)

K

K

K

K

Penicillin

1

1

1

1

Pentazocin

2

2

T

2

Pethidine

2

2

T

2

Phenobarbital (as an anticonvulsant)

T

2

T

T

Phenylbutazone

2

T

T

2

Phenytoin

T

T

T

1

Polyvidon iodine (except small areas)

K

K

K

K

Prazosin

2

2

2

2

Primidone

T

2

T

T

Probenecid

1

1

1

1

Proguanil (malaria prophylaxis)

1

1

1

1

Promethazine

2

2

T

2

Propylthiouracil

1

1

1

1

Prostaglandins

K

K

E

K

Pyrethrum (external)

1

1

1

1

Pyrimethamine

2

2

T

1

Pyrvinium Emboat

1

1

1

1

Ranitidine

2

2

2

2

Radiopharmaceuticals

K

K

K

K

Rifampicin

1

1

1

1

Spironolactone

2

2

2

2

Sulfonamides

2

2

T

2

Terfenadine

2

2

2/E

2/E

Testosterone

K

K

K

K

Tetracyclines

2

K

K

2

Theophylline

1

1

1

1

Thiamazole

2

2

2

2

Thyroxine (L-)

1

1

1

1

Tinidazole

2/E

2/E

2/E

2/E

Tramadol

2

2

T/E

2/E

Tretinoin (external)

K

K

K

2

Valproic acid

T

T

T

1

Verapamil

2

2

2

1

Vitamin A (> 10,000 IU/day)

K

K

K

K

1 = 1st choice product: Generally well tolerated during pregnancy and lactation. Also, these drugs should only be prescribed if their use is superior to a non-drug therapy.

2 = 2nd choice remedy: Only indicated when other therapeutic options fail. Often insufficient testing during pregnancy and lactation.

E = Single dose or low dosage for a maximum of 1-3 days.

K = Contraindicated: because of embryo-fetotoxic potential, possible intolerance during lactation or because there is no rational indication during pregnancy. Extended prenatal diagnosis may be necessary.

T = Potentially toxic: Concerns embryo, foetus, newborn or breastfed infant. Use only in justified individual cases. In case of use, extended prenatal diagnostics may be necessary.


Pharmaceuticals

Indication during pregnancy

Antimycotics

Amorolfin

3

amphotericin B

1

Bifonazole

2

Ciclopirox

3

Clotrimazole

1

Croconazole

2

Econazole

2

Fenticonazole

2

Fluconazole

2

Isoconazole

2

Ketoconazole

2

Naftifin

3

Nystatin

1

Sertaconazole

2

Terbinafine

3

Tioconazole

2

Tolciclat

3

Tolnoftat

3

Glucocorticoids

Glucocorticoids (topical application forms of various active substance classes such as ointments/creams/sg./gels)

No objections to local therapy limited in time and space

Antiparasitosa

Allethrin I

2

Benzyl benzoate

1

Crotamiton

2

Coconut oil

1

Lindane

banned in Germany since 2008!

Pyrethrin

2

Pyrethrum extract

1

vitamin D3 analogues

Calcipotriol

Repeated applications over large areas should be avoided, especially if the effect is favourable to absorption

Dithranol

Repeated applications over large areas should be avoided, especially if the effect is favourable to absorption

Other

5-fluorouracil

Contraindicated (Exception: therapy of single verrucae. In principle, however, an attempt should be made to postpone the therapy until after delivery)

aluminium aceticum

1

Ammonium bituminosulfonate

No objections to local therapy limited in time and space

Ethanol

1

Benzoyl peroxide

May be used for acne treatment of limited areas (e.g. face)

Bufexamac

No objections to local therapy limited in time and space

Quinolinol

Should not be used

Clioquinol

No objections to local therapy limited in time and space

Diethyltoluamide (DEET, Autan)

No safe large-scale application during pregnancy. In malaria areas, the risk associated with the use of DEET is less than the risk of malaria infection

Haemorrhoid remedies

Harmless. The application has been proven safe during pregnancy

Urea

No objections to local therapy limited in time and space

Isopropyl alcohol

1

Camphor

Allowed

Crystal Violet

Small and short-term topical applications are possible

Menthol

Allowed

Methylrosanilinium chloride (gentian violet)

Small and short-term topical applications are possible

pix lithanthracis

Do not use if possible

Polidocanol

Allowed

PUVA therapy (PUVA bath, cream-PUVA)

Not recommended due to possible mutagenic effects

Pyoctanin

Small and short-term topical applications are possible

Mercury compounds

Contraindicated

Retinoids

Contraindicated

Salicylates

No objections to local therapy limited in time and space

Tannin

1

1 = 1st choice product: Generally well tolerated during pregnancy. Also, only prescribe these drugs if their use is superior to a non-drug therapy.

2 = 2nd choice remedy: Only indicated if other therapeutic options fail. Often insufficient testing during pregnancy and lactation.

3 = Agents which should not be used during pregnancy due to insufficient data or for other reasons.


Largely harmless

After risk-benefit analysis

Contraindicated

Pregnancy

Penicillins, cephalosporins, erythromycin (except estolate), fusidic acid

Clavulanic acid, sulbactam, tazobactam, meropenem, imipenem, ertapenem, azithromycin, roxithromycin, clindamycin, vancomycin, teicoplanin, linezolid, fosfomycin

Tetracyclines, chloramphenicol, clarithromycin, TMP/sulfonamides (1st trimester and from 28th week), metronidazole, aminoglycosides, fluoroquinolones, nitrofurantoin, rifampicin, telithromycin, tigecyclin

Breastfeeding period

penicillins, cephalosporins

Clavulanic acid, sulbactam, tazobactam, meropenem, imipenem, ertapenem, azithromycin, roxithromycin, clindamycin, vancomycin, teicoplanin, linezolid, aminoglycosides, fosfomycin

Tetracyclines, chloramphenicol, TMP/sulfonamides, erythromycin, metronidazole, fluoroquinolones, nitrofurantoin, rifampicin, telithromycin, ertapenem, tigecyclin

Authors

Last updated on: 29.10.2020